This was the stock's fifth consecutive day of gains.

Bloomberg launched the Bloomberg Inflation Sensitive Equity Index (BINFLST) in 2022, designed to identify stocks most responsive to inflation dynamics.

Barclays raised the firm’s price target on Boston Scientific (BSX) to $111 from $86 and keeps an Overweight rating on the shares. The firm says ...

For the fourth quarter, the Aristotle Small/Mid Cap Equity Composite generated a total return of -0.45% net of fees, ...

Global shares are mixed in a muted reaction to the inauguration of U.S. President Donald Trump, while U.S. futures have advanced ...

The name points us in the right direction to answer such a question, but what is it that the Boston duo do to generate all ...

Here's what's open and closed on Martin Luther King Jr. Day 2025.

As he assumes the presidency for a second time, Donald Trump brings with him a broad expanse of business relationships and ...

Boston Scientific Corp (NYSE:BSX), a $144.82 billion medical device manufacturer with strong financial health according to InvestingPro analysis, has received preliminary court approval for a ...

US markets extended their gains on Wednesday after the announcement of a Gaza ceasefire agreement between Israel and Hamas, ...

The U.S. Securities and Exchange Commission has sued billionaire Elon Musk, saying he failed to disclose his ownership of ...

We recently published a list of 10 Hottest Mega-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...